September 1, 2019Open Access

Sarcopenia as Prognostic Factor in Lung Cancer Patients: A Systematic Review and Meta-analysis

Key Points

Key points are not available for this paper at this time.

Abstract

Muscle loss is an independent risk factor for increased death risk in lung cancer patients independent of cancer stage. This argues for implementing screening for sarcopenia into cancer care.

Bookmark

View Full Paper

Cite This Study

Buentzel et al. (Sun,) studied this question.

synapsesocial.com/papers/69d90e90cc20f7a91c3aff54 https://doi.org/https://doi.org/10.21873/anticanres.13640

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1A Personalized Physical Activity Program With Activity Trackers and a Mobile Phone App for Patients With Metastatic Breast Cancer: Protocol for a Single-Arm Feasibility Trial2018 · 28 citations
2Changes in skeletal muscle mass during palliative chemotherapy in patients with advanced lung cancer2014 · 215 citations
3Epidemiology of Sarcopenia among the Elderly in New Mexico1998 · 4,025 citations
4ESPEN guidelines on nutrition in cancer patients2016 · 3,008 citations
5Clinical Impact and Risk Factors for Skeletal Muscle Loss After Complete Resection of Early Non-small Cell Lung Cancer2018 · 58 citations

Bookmark

View Full Paper